{"id":1732,"date":"2023-08-08T10:27:36","date_gmt":"2023-08-08T10:27:36","guid":{"rendered":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/therapie-combinee-lenvatinib-pembrolizumab\/"},"modified":"2026-03-31T15:33:36","modified_gmt":"2026-03-31T15:33:36","slug":"combination-therapy-lenvatinibpembrolizumab-2","status":"publish","type":"post","link":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/combination-therapy-lenvatinibpembrolizumab-2\/","title":{"rendered":"Th\u00e9rapie combin\u00e9e: Lenvatinib + Pembrolizumab"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]Les provinces du Qu\u00e9bec et de l&rsquo;Alberta ont ajout\u00e9 le pembrolizumab en association avec le lenvatinib \u00e0 la liste des m\u00e9dicaments fournis en \u00e9tablissement pour le traitement de premi\u00e8re intention des patients adultes atteints d&rsquo;un carcinome \u00e0 cellules r\u00e9nales (CCR) avanc\u00e9 ou m\u00e9tastatique. Les patients admissibles doivent n&rsquo;avoir jamais \u00e9t\u00e9 trait\u00e9s dans un contexte m\u00e9tastatique et avoir un indice fonctionnel favorable.<\/p>\n<p>Le traitement par pembrolizumab doit \u00eatre poursuivi jusqu&rsquo;\u00e0 progression confirm\u00e9e de la maladie ou toxicit\u00e9 inacceptable, jusqu&rsquo;\u00e0 un maximum de 2 ans, selon la premi\u00e8re de ces \u00e9ventualit\u00e9s \u00e0 survenir. Le traitement par lenvatinib doit se poursuivre jusqu&rsquo;\u00e0 progression de la maladie ou toxicit\u00e9 inacceptable.<\/p>\n<p>\u00a0<\/p>\n<p>[\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]Les provinces du Qu\u00e9bec et de l&rsquo;Alberta ont ajout\u00e9 le pembrolizumab en association avec le lenvatinib \u00e0 la liste des m\u00e9dicaments fournis en \u00e9tablissement pour le traitement de premi\u00e8re intention des patients adultes atteints d&rsquo;un carcinome \u00e0 cellules r\u00e9nales (CCR) avanc\u00e9 ou m\u00e9tastatique. Les patients admissibles doivent n&rsquo;avoir jamais \u00e9t\u00e9 trait\u00e9s dans un contexte m\u00e9tastatique [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1733,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"year-of-the-new":[54],"class_list":["post-1732","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee","year-of-the-new-54"],"_links":{"self":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/1732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/comments?post=1732"}],"version-history":[{"count":1,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/1732\/revisions"}],"predecessor-version":[{"id":1734,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/1732\/revisions\/1734"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media\/1733"}],"wp:attachment":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media?parent=1732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/categories?post=1732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/tags?post=1732"},{"taxonomy":"year-of-the-new","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/year-of-the-new?post=1732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}